Insulin glargine and lixisenatide Subcutaneous and Supartz FX
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Supartz FX and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: sodium hyaluronate
Brand name: Euflexxa, Gel-One, GenVisc 850, Hyalgan, Monovisc, Orthovisc, Supartz, Supartz FX, Synvisc, Synvisc-One, Durolane, Gelsyn-3, Visco-3, Trivisc
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Supartz FX Injection
- Insulin glargine and lixisenatide Subcutaneous-Supartz injection
- Insulin glargine and lixisenatide Subcutaneous-Super Cold Tabs
- Insulin glargine and lixisenatide Subcutaneous-Super Dent Topical Anesthetic Gel
- Insulin glargine and lixisenatide Subcutaneous-Super Strength Sinadrin
- Insulin glargine and lixisenatide Subcutaneous-SuperiorSource K1
- Supartz FX-Insulin glargine, recombinant Subcutaneous
- Supartz FX-Insulin glulisine
- Supartz FX-Insulin Glulisine (Cartridges and Pens)
- Supartz FX-Insulin Glulisine (Vials)
- Supartz FX-Insulin glulisine Subcutaneous
- Supartz FX-Insulin human inhaled Inhalation